These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26038420)

  • 1. The role of biomedical research in global tuberculosis control: gaps and challenges: A perspective from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health.
    Sizemore CF; Schleif AC; Bernstein JB; Heilman CA
    Emerg Microbes Infect; 2012 Jul; 1(7):e9. PubMed ID: 26038420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research resources for tuberculosis at the National Institute of Allergy and Infectious Diseases.
    NIH, DMID TB program
    Tuberculosis (Edinb); 2013 Jan; 93(1):6-11. PubMed ID: 23385001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019.
    Yeung DT; Bough KJ; Harper JR; Platoff GE
    J Med Toxicol; 2020 Jan; 16(1):87-105. PubMed ID: 31853736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIAID funds adult AIDS clinical trials group. National Institute of Allergy and Infectious Diseases.
    Folkers G
    NIAID AIDS Agenda; 1995 Dec; ():1, 14-5. PubMed ID: 11363348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investments in tuberculosis research - what are the gaps?
    Khan MS; Fletcher H; ; Coker R
    BMC Med; 2016 Aug; 14(1):123. PubMed ID: 27558175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patient-centered medicine for tuberculosis medical services].
    Fujita A; Narita T
    Kekkaku; 2012 Dec; 87(12):795-808. PubMed ID: 23350521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Funding Research Through the Online Partnership to Accelerate Research (OnPAR).
    Dueñas MA; Bisceglio I
    JACC Basic Transl Sci; 2016 Oct; 1(6):536-540. PubMed ID: 30167536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies.
    D'Onofrio G; Jauch E; Jagoda A; Allen MH; Anglin D; Barsan WG; Berger RP; Bobrow BJ; Boudreaux ED; Bushnell C; Chan YF; Currier G; Eggly S; Ichord R; Larkin GL; Laskowitz D; Neumar RW; Newman-Toker DE; Quinn J; Shear K; Todd KH; Zatzick D;
    Ann Emerg Med; 2010 Nov; 56(5):551-64. PubMed ID: 21036295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of programs to support new investigators at the National Institute of Allergy and Infectious Diseases: Striking a balance with funding for established investigators.
    Zane AC; Onken J; Parker MB; Ghosh D
    Eval Program Plann; 2023 Jun; 98():102218. PubMed ID: 36963190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killen discusses NIAID strategy, progress in HIV vaccine research and development. National Institute of Allergy and Infectious Diseases.
    Killen J
    NIAID AIDS Agenda; 1995 Sep; ():1, 10-2. PubMed ID: 11362800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.
    Taylor Z; Nolan CM; Blumberg HM; ; ;
    MMWR Recomm Rep; 2005 Nov; 54(RR-12):1-81. PubMed ID: 16267499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TB back with a vengeance.
    Indian Med Trib; 1993 Nov; 1(9):4. PubMed ID: 12179170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and new directions in genetics of tuberculosis: an NHLBI working group report.
    Smith I; Nathan C; Peavy HH;
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1491-6. PubMed ID: 16192449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIAID AIDS vaccine research: a conversation with Dr. Carole Heilman. National Institute of Allergy and Infectious Diseases. Interview by Sarah Landry.
    Heilman C
    NIAID AIDS Agenda; 1998 Aug; ():8-9, 11-2. PubMed ID: 11365727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.